October 2024 Provider Newsletter

Contents

AdministrativeCommercialOctober 1, 2024

Provider manual update available

AdministrativeCommercialOctober 1, 2024

Drug fee schedule update

AdministrativeCommercialOctober 1, 2024

National Accounts 2025 precertification list

Digital SolutionsMedicare AdvantageOctober 1, 2024

Introducing the Care Provider Recognition Program from Anthem

Digital SolutionsCommercialMedicare AdvantageSeptember 12, 2024

Roster Automation updates effective November 15, 2024: enhanced reporting to increase data accuracy

Digital SolutionsCommercialMedicare AdvantageSeptember 4, 2024

Digital Provider Enrollment now available for additional provider types in Availity Essentials

Education & TrainingMedicare AdvantageSeptember 16, 2024

Seamless advance care: MyDirectives digital tool for D-SNP members

Policy UpdatesMedicare AdvantageSeptember 3, 2024

Clinical Criteria updates

Medical Policy & Clinical GuidelinesMedicare AdvantageSeptember 10, 2024

Medical Policies and Clinical Utilization Management Guidelines update

Prior AuthorizationMedicare AdvantageSeptember 23, 2024

Prior authorization requirement changes

PharmacyCommercialOctober 1, 2024

Material adverse change

Prior authorization updates for specialty pharmacy — October 2024

PharmacyCommercialOctober 1, 2024

Pharmacy information available on our provider website

Quality ManagementCommercialMedicare AdvantageOctober 1, 2024

Prevent flu and COVID-19: drive the change through vaccination

Quality ManagementCommercialMedicare AdvantageOctober 1, 2024

HEDIS medical record submission made easier with our Remote EMR Access service

COBCBS-CRCM-067858-24

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

AdministrativeCommercialOctober 1, 2024

Provider manual update available

Anthem reviews and updates our provider manuals annually so our care provider partners have the current information needed to work with us.

The updated Commercial provider manual effective January 1, 2025, is now available on our public provider website at anthem.com.

To view the updated manual, visit the provider webpage on anthem.com.

  • Select Colorado at the top of the webpage, if needed.
  • Scroll down and select Policies, Guidelines & Manuals.
  • Scroll to Provider Manual and select Download the Manual.
  • On the Provider Manual page, scroll down to the green section Looking for Our Upcoming Provider Manual and select Preview the upcoming manual.

Select Access previous versions and other manuals to view our Provider Manual Library for all current and historical provider manuals available.

We are excited for genuine collaboration with you, our care provider partners.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

COBCBS-CM-068847-24

AdministrativeCommercialOctober 1, 2024

Drug fee schedule update

Routinely, the Centers for Medicare & Medicaid Services (CMS) issues revisions to the average sales price (ASP) fee schedules regarding drug pricing. To that end, CMS is supplying the fourth quarter fee schedule with an effective date of October 1, 2024. This will go into effect with Anthem on November 1, 2024. To view the ASP fee schedule, visit the CMS website.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-066531-24

AdministrativeCommercialOctober 1, 2024

National Accounts 2025 precertification list

The National Accounts 2025 Pre-certification List has been published. Please note, care providers should continue to verify member eligibility and benefits prior to rendering services.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-066138-24-SRS64578

ATTACHMENTS (available on web): National Accounts 2025 Pre-certification List (pdf - 1.52mb)

Digital SolutionsMedicare AdvantageOctober 1, 2024

Introducing the Care Provider Recognition Program from Anthem

Celebrating extraordinary impacts on health:

  • The new Care Provider Recognition Program honors excellence in Medicare patient care.
  • The annual program launching in the fall of 2024 will award top healthcare providers.
  • Winners will be chosen based on quality measures and good standing with health plans.

We’re committed to going beyond the contract to make a real impact on health together with our care providers. To celebrate and appreciate our care provider partners for outstanding performance in patient care, we’re excited to announce our new Care Provider Recognition Program.

This program honors successes and highlights those who are driving toward better outcomes. It provides care providers with an opportunity to thank and celebrate teams for going above and beyond to deliver high-quality, cost-efficient care, while driving health equity and exceptional patient experiences, and outcomes.

Launching in the fall of 2024, this annual program will recognize care providers who deliver excellence in care to their Medicare patients, our members — which makes it different from other distinctions in the industry. Winners of the 2024 Care Provider Recognition Award will be announced in mid-‑December. 

Winners will be selected based on the following criteria:

  • Top 5% of care providers based on quality measured through our internal Medicare data based on current performance and three-year average, including medical best practices such as preventive care screenings, immunizations, chronic disease management, and medication adherence
  • In-network and contract in good standing with an affiliated health plan

Driving toward better health outcomes is a critical shared goal with our care provider partners, and results like these are worthy of the spotlight.

We are committed to finding solutions that help our care provider partners offer quality services to our members.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-066623-24-CPN65972

Digital SolutionsCommercialMedicare AdvantageSeptember 12, 2024

Roster Automation updates effective November 15, 2024: enhanced reporting to increase data accuracy

At a glance:

  • Care providers will use the Error Report function in Availity Essentials to identify, rectify, and resubmit errors in rosters.
  • The new Results Report is available to view.
  • Both the Error and Results Reports can be found on the Upload Roster File page of Availity, with additional guidance available in the Roster Submission Guide.

Error Report an essential tool to identify and correct mistakes

As previously communicated, we introduced an Error Report to the Upload Roster File screen in Availity Essentials Provider Data Management (PDM). Care providers can use this Error Report to understand where errors occurred (specifically which sheet, tab, and row), the cause of the issue, and how to fix it.

As a reminder, you will need to correct any errors submitted in a roster (for example, missing data or incorrectly formatted data) in the future. Rows in a roster that contain an error will not be processed and the addition, change, or termination will not be updated in our systems.

Effective November 15, 2024, care providers are responsible for using the Error Report to identify errors in a roster, correct them, and resubmit the roster rows that contain errors. Rows in a roster that contain an error will not be processed and the addition, change, or termination will not be updated in our systems.

New Results Report identifies added and updated records

For better transparency for our care providers, we’ve now introduced a new Results Report that allows care providers to see the number of unique records that were added or updated based on a specific roster. The Results Report also contains data elements associated with the records, including NPI, TIN, name, address, and effective date. Think of it as a receipt of the actions taken to keep your demographic information accurate. A Results Report has been created for rosters received on and after June 15, 2024.

Both reports are on the Upload Roster File page of Availity

You can find the Results Report, as well as the Error Report, on the Upload Roster File page of Availity PDM. Future informational webinars are coming soon — Watch for updates in the Provider Newsletter.

Use the Roster Submission Guide

Additional information about the Results Report and Error Report can be found in our Roster Submission Guide. Find it online at Availity.com > Payer Spaces > Select Payer Tile > Resources > Roster Submission Guide using Provider Data Management.

Access our previous communications below

Colorado
Connecticut
Georgia
Missouri
New Hampshire
Ohio
Virginia

We look forward to working together to achieve improved outcomes.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-065233-24-CPN64476

Digital SolutionsCommercialMedicare AdvantageSeptember 4, 2024

Digital Provider Enrollment now available for additional provider types in Availity Essentials

On September 23, 2024, Anthem will add new specialties to the Provider Enrollment tool hosted on Availity Essentials to further automate and improve your online enrollment experience.  

Who can use this new tool?

  • Therapy providers (physical therapist, occupational therapist, and speech therapist)
  • Audiologists and hearing aid fitters
  • Registered dieticians (Independent providers should enroll through American Specialty Health (ASH) at ashcompanies.com/Contact or 800-972-4226)
  • Acupuncturists

What does the tool provide?

  • Enroll as an individual provider.
  • Enroll a new group of providers.
  • Apply and request a contract. After review, a contract can be sent back to you digitally for an electronic signature. This eliminates the need for paper applications or paper contracts.
  • Use a dashboard for real time status on the submitted applications.
  • Experience streamlined complete data submission.

Reviewing how the online enrollment application works

Availity’s online application will guide you throughout the enrollment process and provide status updates using a dashboard. As a result, you will know where each provider is in the application process without having to call or email for a status update.

Please note: For any changes to your practice profile, adding or deleting practitioners, and updating demographics, use the Provider Data Management (PDM) application on Availity Essentials that allows you to electronically submit any changes to your practice profile and demographics. Availity administrators and assistant administrators can access PDM by going to Availity > My Providers > Provider Data Management.

Accessing the Provider Enrollment application

Log on to Availity Essentials and select Payer Spaces > Anthem > Applications > Provider Enrollment to begin the enrollment process.

If your organization is not currently registered for Availity Essentials, the person in your organization designated as the Availity administrator should go to Availity.com and select Register.

For organizations already using Availity Essentials, your organization's Availity administrator should go to My Account Dashboard from the Availity home page to register new users and update or unlock accounts for existing users. Staff who need access to the Provider Enrollment tool need to be granted the role of Provider Enrollment. Availity administrators and user administrators will automatically be granted access to Provider Enrollment.

If you are using Availity Essentials today and need access to Provider Enrollment, please work with your organization’s administrator to update your Availity Essentials role. To determine who your administrator is, you can go to My Account Dashboard > My Administrators.

Need assistance with registering for Availity Essentials?

Contact Availity Client Services at 800-282-4548.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-059932-24-CPN59787

Education & TrainingMedicare AdvantageSeptember 16, 2024

Seamless advance care: MyDirectives digital tool for D-SNP members

At a glance:

  • Members enrolled in Dual Eligible Special Needs Plan (D-SNP) can have free access to MyDirectives to manage advance directives digitally.
  • Providers should discuss the importance of advance directives with patients during annual wellness visits.
  • Members can access MyDirectives through their member website to easily create, upload, and share advance directives.


Anthem is providing all Medicare Advantage members enrolled in a Dual Eligible Special Needs Plan (D-SNP) with free access to MyDirectives, an advance directives creation tool.

What is MyDirectives?

MyDirectives is a digital tool that can be used to easily create, maintain, and share information on advance directives. It has an easy-to-use guide that takes members through a series of questions about their care preferences, the establishment of healthcare agents (medical powers of attorney), the sharing of information, and more.

Your role as a provider

To support the successful delivery of person-centered care, providers should speak to their patients about the value of establishing an advance directive during the annual wellness visit. The CMS recently revised its advance care planning (ACP) fact sheet, which includes important documentation and time requirements for this service.

How members access and use MyDirectives

To get started with the Advance Directives program, members can visit the Anthem member website and select the Benefits tab to access the link for the Advance Directives program. Selecting this link will take the member to the MyDirectives app, where they can create a free account or link an existing account:

  • If they already have a written advance directive, MyDirectives allows members to upload copies of their current directives, making it easier to store and share when necessary.
  • Members can create a contact list of individuals who can have access to their advance directives, including physicians. A member’s advance directive can also be retrieved through national data exchanges such as eHealth Exchange, Carequality, and CommonWell Health Alliance.

MyDirectives customer support:

  • MyDirectives offers online customer support, which is the preferred contact method.
    Members can also call 888-884-3324 or email support@mydirectives.com.

We share a health vision with our care providers that means real change for consumers.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-068079-24

Policy UpdatesMedicare AdvantageSeptember 3, 2024

Clinical Criteria updates

Effective October 4, 2024

Summary: On June 10, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other providers in your practice and office staff.

Please note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

October 4, 2024

*CC-0263

Imdelltra (tarlatamab-dlle)

New

October 4, 2024

*CC-0264

Anktiva (nogapendekin alfa inbekicept-pmln)

New

October 4, 2024

*CC-0265

Kisunla (donanemab)

New

October 4, 2024

*CC-0166

Trastuzumab Agents

Revised

October 4, 2024

CC-0187

Breyanzi (lisocabtagene maraleucel)

Revised

October 4, 2024

CC-0118

Radioimmunotherapy and Somatostatin Receptor Targeted Radiotherapy (Azedra, Lutathera, Pluvicto, Zevalin)

Revised

October 4, 2024

CC-0094

Pemetrexed (Alimta, Pemfexy, Pemrydi)

Revised

October 4, 2024

CC-0032

Botulinum Toxin

Revised

October 4, 2024

*CC-0041

Complement C5 Inhibitors

Revised

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-063982-24-CPN63395

Medical Policy & Clinical GuidelinesMedicare AdvantageSeptember 10, 2024

Medical Policies and Clinical Utilization Management Guidelines update

Effective October 10, 2024

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter Two, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary.

Please share this notice with other providers in your practice and office staff.

To view a guideline, visit https://anthem.com/provider/policies/clinical-guidelines.

Notes/updates

Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive:

  • MED.00055 - Wearable Cardioverter Defibrillators:
    • Reformatted language from the to a wearable cardioverter defibrillator and moved punctuation
    • Added Not Medically Necessary statement when individual has an automated external defibrillator
  • RAD.00069 - Absolute Quantitation of Myocardial Blood Flow Measurement:
    • The use of absolute quantitation of myocardial blood flow testing is considered Investigational & Not Medically Necessary for all indications
  • SURG.00011 – Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting:
    • Revised ocular indications, including the addition of SurSight to Medically Necessary and Not Medically Necessary section and added new Medically Necessary criterion addressing non-healing or persistent corneal epithelial defects
    • Removed VersaWrap from Investigational & Not Medically Necessary statement
    • Removed Phasix Mesh from Investigational & Not Medically Necessary statement
    • Added Phasix Mesh and Phasix ST Mesh to Medically Necessary and Not Medically Necessary statements
  • CG-DME-54 - Mechanical Insufflation-Exsufflation Devices:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for use of mechanical insufflation-exsufflation devices

Medical Policies

On May 9, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These Medical Policies take effect October 10, 2024.

Publish Date

Medical Policy Number

Medical Policy Title

New or Revised

6/28/2024

ANC.00009

Cosmetic and Reconstructive Services of the Trunk, Groin, and Extremities

Revised

6/28/2024

*MED.00055

Wearable Cardioverter Defibrillators

Revised

6/28/2024

*RAD.00069

Absolute Quantitation of Myocardial Blood Flow Measurement

New

6/28/2024

*SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Revised

6/28/2024

SURG.00121

Transcatheter Heart Valve Procedures

Revised

Clinical UM Guidelines

On May 9, 2024, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicare Advantage members on June 27, 2024. These guidelines take effect October 10, 2024.

Publish Date

Clinical UM Guideline Number

Clinical UM Guideline Title

New or Revised

6/28/2024

*CG-DME-54

Mechanical Insufflation-Exsufflation Devices

New

6/28/2024

CG-DME-55

Automated External Defibrillators for Home Use

New

6/28/2024

CG-MED-68

Therapeutic Apheresis

Revised

6/28/2024

CG-MED-97

Biofeedback and Neurofeedback

New

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-066602-24-CPN65660

Prior AuthorizationMedicare AdvantageSeptember 23, 2024

Prior authorization requirement changes

Effective January 1, 2025

Effective January 1, 2025, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicare Advantage members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims.

Prior authorization requirements will be added for the following code(s):

Code

Description

0141U

Infectious disease (bacteria and fungi), gram-positive organism identification and drug resistance element detection, DNA (20 gram-positive bacterial targets, 4 resistance genes, 1 pan gram-negative bacterial target, 1 pan Candida target), blood culture, amplified probe technique, each target reported as detected or not detected ePlex® BCID Gram-Positive Panel, GenMark Diagnostics, Inc, GenMark Diagnostics, Inc

0142U

Infectious disease (bacteria and fungi), gram-negative bacterial identification and drug resistance element detection, DNA (21 gram-negative bacterial targets, 6 resistance genes, 1 pan gram-positive bacterial target, 1 pan Candida target), amplified probe technique, each target reported as detected or not detected ePlex® BCID Gram-Negative Panel, GenMark Diagnostics, Inc, GenMark Diagnostics, Inc

0321U

Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 20 bacterial and fungal organisms and identification of 16 associated antibiotic-resistance genes, multiplex amplified probe technique Bridge Urinary Tract Infection Detection and Resistance Test, Bridge Diagnostics

0369U

Infectious agent detection by nucleic acid (DNA and RNA), gastrointestinal pathogens, 31 bacterial, viral, and parasitic organisms and identification of 21 associated antibiotic-resistance genes, multiplex amplified probe technique

0370U

GI assay (Gastrointestinal Pathogen with ABR), Lab Genomics LLC, Thermo Fisher Scientific

0373U

Infectious agent detection by nucleic acid (DNA and RNA), respiratory tract infection, 17 bacteria, 8 fungus, 13 virus, and 16 antibiotic-resistance genes, multiplex amplified probe technique, upper or lower respiratory specimen

0445U

β-amyloid (Abeta42) and phospho tau (181P) (pTau181), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology

0524T

Elecsys® PhosphoTau (181P) CSF (pTau181) and βAmyloid (1-42) CSF II (Abeta 42) Ratio, Roche Diagnostics Operations, Inc (US owner/operator)

21086

Impression & Custom Preparation; Auricular Prosthesis

36473

Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, mechanochemical; first vein treated

36482

Endovenous ablation therapy of incompetent vein, extremity, by transcatheter delivery of a chemical adhesive (eg, cyanoacrylate) remote from the access site, inclusive of all imaging guidance and monitoring, percutaneous; first vein treated

64568

Open implantation of cranial nerve (eg, vagus nerve) neurostimulator electrode array and pulse generator

A2026

Restrata MiniMatrix, 5 mg

A4438

Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each

C1734

Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)

C9796

Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [SIS])

C9797

Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction

L5991

Addition to lower extremity prostheses, osseointegrated external prosthetic connector

L8045

Auricular Prosthesis

Q4305

American Amnion AC Tri-Layer, per sq cm

Q4306

American Amnion AC, per sq cm

Q4307

American Amnion, per sq cm

Q4308

Sanopellis, per sq cm

Q4309

VIA Matrix, per sq cm

S9002

Intravaginal motion sensor system, provides biofeedback for pelvic floor muscle rehabilitation device

Not all PA requirements are listed here. Detailed PA requirements are available to providers on https://anthem.com/provider/medicare-advantage on the Resources tab or for contracted providers by accessing Availity.com.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-066981-24-CPN66375

Reimbursement PoliciesMedicare AdvantageOctober 1, 2024

Clarification to reimbursement policy update: Nurse Practitioner and Physician Assistant Services

(Policy G-20002, effective 11/01/2024)

In the August 2024 edition of the Provider News, we announced an update to the Nurse Practitioner and Physician Assistant Services policy. To clarify, we are aligning the reimbursement policy with Centers for Medicare & Medicaid Services (CMS) guidelines to indicate which services will be eligible for a payment reduction according to the Nurse Practitioner and Physician Assistant Services reimbursement structure.

The following services were removed from the policy and are eligible for a payment reduction when billed by NP/PA provider.

    • Preventive Services
    • Radiology Services

The following physician’s services are not subject to the NP/PA reimbursement payment reduction and the services are included in the not considered for payment reduction section.

    • Drugs
    • Durable Medical Equipment Prosthetics, Orthotics, and Supplies (DMEPOS)
    • Laboratory Services and Laboratory Screening Services

For specific policy details visit the reimbursement policy page

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-066719-24-CPN66373

Reimbursement PoliciesCommercialOctober 1, 2024

Material adverse change

Reimbursement policy update: Modifiers 59 and XE, XP, XS, and XU: Distinct Procedural Service — Professional

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

COBCBS-CM-067504-24

ATTACHMENTS (available on web): Reimbursement policy update: Modifiers 59 and XE, XP, XS, and XU: Distinct Procedural Service — Professional (pdf - 0.19mb)

Products & ProgramsCommercialOctober 1, 2024

Introduction of the HPP designation program for individual member (Exchange) networks

In our February 2024 letter, Anthem informed you that we were implementing a new High Performing Provider (HPP) designation to care providers meeting certain cost and quality metrics as part of our expansion of consumer tools and programs. Additionally, we indicated the designation will initially focus on certain types of professional providers we categorize as primary care providers (PCPs), but it may be broadened to include other care provider types in the future.

Effective on or about November 15, 2024, Anthem will use a new HPP methodology (cost and quality metrics) to designate HPPs for PCPs participating in our individual member (Exchange) plan networks that service our Affordable Care Act plans (IND HPPs). The new IND HPP methodology will be tailored for our Exchange plans.

Anthem will continue to use the methodology we notified you about in our February 2024 letter (the methodology was included in that communication) for our non-Exchange commercial health plan networks.

As with the non-Exchange HPP designation, Anthem may highlight Exchange HPPs in various ways, including, but not limited to:

  • Providing special opportunities to participate in product offerings.
  • When members contact Anthem with requests for referral options.
  • Placing a designation in the Care and Cost Finder. This would be in addition to Anthem’s existing tool in Care and Cost Finder called Personalized Match, which provides Anthem members with the option to search for in-network care providers through a specialized sorting tool that considers certain cost and quality metrics as well.
  • Designating a factor in auto assignment PCP methodology for health benefit plans, which require a member to pick a PCP and the member fails to do so.

As shown in the IND HPP methodology, the IND HPP methodology for determining an IND HPP is virtually the same as the methodology for determining an HPP in general (which services the health plan’s large and small group commercial populations); however, certain metrics may solely apply to the individual member population. The IND HPP designation is solely for PCPs seeing an individual member population and not for specialists.

You can view the IND HPP designation methodology here. For more information on the individual member (Exchange) HPP designation or to know if your practice will receive the IND HPP designation, please contact your local provider relationship management representative.  

Review process

If you have questions or if you would like additional information or details about whether or not you will receive the designation or the designation methodology in general, please contact your local provider relationship management representative.

Anthem will continue to focus and expand our consumer tools and content to assist members in making more informed and personalized healthcare decisions. As always, thank you for participating in our networks, and we look forward to working collaboratively with you to provide our members with continued access to affordable and quality healthcare.

Process for requesting more information/reconsideration

If you would like more information on the methodology and/or data upon which a score is based or if you believe there is an error with your quality or cost results, you may request reconsideration and/or more information by contacting your local provider relationship management representative. Such requests must be made no later than November 15, 2024. To ensure that we properly address your concerns, please include in your email why you believe there is an error and/or the information you request. You may also submit via email any additional information or data you believe may be relevant to the determination.

You have the right to request a face-to-face meeting with those responsible for the appeal decision. To exercise this right, please indicate in your email your desire to have such a meeting. Upon receipt of such a request, we will schedule a time and date for the meeting, which will be held at a location reasonably convenient to you or by teleconference on or before December 1, 2024. Please note that you have the right to be assisted by a representative in any request for reconsideration.

Upon receipt of a request for reconsideration, one or more of the following will review your request and make a decision:

  • Jonathan Sollender, MD, MBA, FACS Regional Vice President and Senior Clinical Officer
  • Erica Kloehn, RVP, Provider Solutions
  • Helene Coley, Staff Vice President, Provider Analytics

You will be notified of the decision and the basis for the decision in a letter on or before
January 1, 2025.

Updates to HPP designation program

Please continue to look for updates to our HPP designation program in this provider newsletter. If you do not currently subscribe to our provider newsletter, you can do so by going to https://providernews.anthem.com/colorado.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

COBCBS-CM-062461-24-SRS62461

ATTACHMENTS (available on web): Individual Member (Exchange) High Performing Provider designation (pdf - 1.01mb)

PharmacyCommercialOctober 1, 2024

Material adverse change

Prior authorization updates for specialty pharmacy — October 2024

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

COBCBS-CM-067802-24-CPN67634

ATTACHMENTS (available on web): Prior authorization updates for specialty pharmacy — October 2024 (pdf - 0.08mb)

PharmacyMedicare AdvantageOctober 1, 2024

Medicare Part D overhaul: What's new in 2025 for your prescription drug costs?

At a glance:

  • Significant Medicare Part D updates in 2025 include a $2,000 out-of-pocket cap and elimination of the coverage gap.
  • Enhanced benefits will remove cost-sharing in catastrophic coverage and expand low-income subsidies to 150% of the federal poverty level (FPL).
  • The Medicare Prescription Payment Plan (M3P) will allow members to spread out prescription costs over the year for added financial flexibility.

What's changing in 2025?

Changes in deductible and out-of-pocket thresholds

In 2024, the standard deductible was $545 with the initial coverage limit at $5,030, and the catastrophic coverage threshold was $8,000. By 2025, the deductible will increase to $590, and members will enter the catastrophic phase when their out-of-pocket expenditure reaches $2,000. Members might see higher upfront costs due to the increased deductible, but reaching catastrophic coverage will be significantly easier, offering greater financial protections much sooner.

Elimination of the coverage gap (donut hole)

The elimination of the coverage gap will simplify the benefit structure. Previously, beneficiaries paid 25% of the cost of both brand-name and generic drugs in the coverage gap. The full elimination of this gap will remove the phase where members faced higher out-of-pocket costs, reducing financial uncertainty and streamlining the benefits process.

Introduction of a $2,000 out-of-pocket cap

In 2025, after reaching the $2,000 out-of-pocket cap, members will no longer have to pay added costs for their medications for the remainder of the year. This offers financial protection and predictability in managing healthcare expenses, helping those with high prescription drug costs.

Elimination of cost-sharing in catastrophic coverage

While in 2024, members had to pay 5% of drug costs after reaching the out-of-pocket threshold; this requirement will lift entirely in the next year. This ensures complete coverage once members reach the catastrophic phase, removing the financial burden for members with extremely high drug costs.

Enhanced low-income subsidy (LIS) benefits

We are also introducing enhanced LIS benefits, extending full benefits to individuals with incomes up to 150% of the FPL from the previous 135% FPL threshold. This change means more members will qualify for full LIS benefits, reducing their premiums, deductibles, and copayments, which improves access to necessary medications for low-income beneficiaries.

Introduction of the Medicare Prescription Payment Plan (M3P)

M3P allows members to manage their out-of-pocket Medicare Part D drug costs by spreading the total sum of their filled prescription costs across the calendar year. This option is voluntary, free to enroll, and members can choose to participate at any point during the year. Instead of paying at the pharmacy, members will receive a bill from their health or drug plan to pay for their prescription drugs each month, offering greater financial flexibility and predictability.

Action plan and resources

To ensure a smooth transition, we’ve laid out a comprehensive educational and communication strategy:

  • Information campaign: As of July 2024, we began an extensive marketing and educational campaign, including public relations efforts, direct member communications, and care provider briefings.
  • Training and support: We are providing training materials, talking points, and FAQs to our support teams, ensuring they are well-prepared to assist you.

Key dates:

  • October 15, 2024: Enrollment in M3P begins
  • January 1, 2025: All other M3P requirements become effective

Next steps:

  • Care providers should stay up to date and make use of the resources we provide to better assist patients. Staying updated on any changes in the formulary and benefit structures will ensure that you can provide the highest quality care possible.
  • Members should keep an eye out for detailed communications about their enhanced Medicare Part D coverage. Members can contact our support team for personalized assistance.

Contact us

Availity Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to Availity.com and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.

For additional support, visit the Contact Us section of our provider website for the appropriate contact.

As we move into 2025, our goal is to provide you with the knowledge and resources needed to maximize the new Medicare Part D benefits. Thank you for trusting us to help manage your healthcare needs.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-067660-24-CPN65205

PharmacyCommercialOctober 1, 2024

Pharmacy information available on our provider website

Visit the Drug Lists page on our website at anthem.com/ms/pharmacyinformation/home.html for more information about:

  • Copayment/coinsurance requirements and their applicable drug classes.
  • Drug lists and changes.
  • Prior authorization criteria.
  • Procedures for generic substitution.
  • Therapeutic interchange.
  • Step therapy or other management methods subject to prescribing decisions.
  • Any other requirements, restrictions, or limitations that apply to using certain drugs.

The commercial and exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October.

To locate the exchange, select Formulary and Pharmacy Information and scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed.

Federal Employee Program pharmacy updates and other pharmacy related information may be accessed at fepblue.org > Pharmacy Benefits.

Please call provider services to request a copy of the pharmaceutical information available online if you do not have internet access.

Through our efforts, we are committed to reducing administrative burden because we value you, our care provider partner.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-068346-24

Quality ManagementCommercialMedicare AdvantageOctober 1, 2024

Prevent flu and COVID-19: drive the change through vaccination

  • Encourage patients to get flu and COVID-19 vaccines for overall health safety.
  • Use resources from LetsVaccinate.org, the CDC, and the American Lung Association to raise vaccination rates.
  • Research validates that vaccinations prevent severe COVID-19 outcomes and significantly lower the risk of intensive care unit (ICU) admission and death from flu.

You care about your patients and want to keep them healthy. That’s why it’s important that you and your care team remind your patients to stay up to date with their flu and COVID-19 vaccines. Physician recommendation is the greatest motivator for people to vaccinate themselves and their family members. Customized patient outreach can influence your patients’ decisions to get recommended vaccines.

The tools below were developed by clinical experts to support you and your care team in educating your patients on the health benefits of vaccines:

  • Let's Vaccinate provides ready-to-use resources and strategies to help your care team increase vaccination rates.
  • CDC’s vaccine information for healthcare professionals offers evidence-based immunization strategies and best practices critical to implementing a successful vaccination program.
  • Fend Off Flu is the American Lung Association’s campaign to increase flu knowledge and vaccination rates.

Research shows:

  • In a 2021 study among adults hospitalized with flu, vaccinated patients had a 26% lower risk of ICU admission and a 31% lower risk of death from flu compared with those who were unvaccinated.*
  • COVID-19 vaccinations remain the safest strategy for avoiding hospitalizations, long-term health outcomes, and death from COVID-19.*

We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities.

* cdc.gov/covid/vaccines/benefits.html?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-065074-24-CPN64664

Quality ManagementCommercialMedicare AdvantageOctober 1, 2024

HEDIS medical record submission made easier with our Remote EMR Access service

Instead of submitting medical records for the HEDIS® hybrid project, use our Remote EMR Access service. We offer providers the ability to grant access to your electronic medical record (EMR) system directly to pull the required documentation to aid your office in reaching compliance. Granting our team remote access to your EMR helps reduce the time and costs associated with medical record retrieval while improving efficiency and allowing your office to focus on patient care.

We have a centralized EMR team experienced with multiple EMR systems and extensively trained annually on HIPAA, EMR systems, and HEDIS measure updates. We complete medical record retrieval based on minimum necessary guidelines:

  • We only access medical records of members pulled into the HEDIS sample using specific demographic data.
  • We only retrieve the medical records that have claims evidence related to the HEDIS measures.
  • We only access the least amount of information needed for a use, disclosure, or a request.
  • We only save to file and do not physically print any PHI.

Getting started with Remote EMR Access is just one email away. Email Centralized_EMR_Team@anthem.com today.

Frequently asked questions

Q. How do you retrieve our medical records?
A. We access your EMR using a secure website and retrieve only the necessary documentation by printing to an electronic file we store internally on our secure network drives.

Q. Is this process secure?
A. Yes, we only use secure internal resources to access your EMR systems. All retrieved records are stored on our secure network drives.

Q. Why does the health plan need full access to the entire medical record?
A. There are several reasons we need to look at the entire medical record of a member:

  • HEDIS measures can include up to a six-year lookback of member’s information.
  • Medical record data for HEDIS compliance may come from several different areas of the EMR system, including labs, radiology, surgeries, inpatient stays, outpatient visits, and case management.
  • Compliant data may be documented or housed in a non-standard format, such as an in-office lab slip scanned into miscellaneous documents.

Q. What information do I need to submit to use your Remote EMR Access service?
A. Email Centralized_EMR_Team@anthem.com with the following information:

  • Practice/facility demographic information (for example, address, national provider ID, or taxpayer identification numbers)
  • EMR system information (for example, type of EMR system, required access forms, or access type)
  • List of current providers/locations or a website for accessing this list

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-065361-24-CPN64123